Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Finasteride use during early pregnancy may cause limb deformities in babies.

Genetic variations contribute to over 10% of recurrent early pregnancy loss cases.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

The HoxC gene cluster and its enhancers are essential for developing hair and nails in mammals.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Addressing skin changes during pregnancy is important to reduce stress for expectant mothers.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Pregnancies in a woman with the Donohue mutation were managed with genetic testing, resulting in three healthy infants.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Educational efforts can reduce harmful chemical exposure from hair products in pregnant Women of Color.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Hair cortisol levels can show increased stress during late pregnancy but only for up to six months.

Prolactin may affect hair growth differently based on gender and scalp area.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

The plant combination effectively repairs skin and delays aging.

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Androgens boost certain nest-building behaviors and greatly reduce food intake in rabbits.

The effects of estrogen on human scalp hair growth are unclear and need more research.

LC-MS/MS is essential for accurately detecting pregnanes in pregnant mares.